Extracorporeal Shockwave Therapy (ECSWT)
ECSW technology provides a versatile regenerative device that increases local blood flow and cellular activity, breaks down calcification and adhesions, and relaxes connective tissue.
Shockwaves have been used successfully in Europe for over a decade for conditions ranging from heart disease and kidney stones to orthopedics. Benefits include increased local blood flow, release of substance P, prostaglandin E2, NO, TGF β, VEGF, and other inflammatory cytokines, breakdown of calcific deposits, and relaxation of connective tissue.
